Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

86
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
86
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel.

bioRxiv : the preprint server for biology·2026
Same author

Perioperative Apalutamide in High-Risk Localized Prostate Cancer.

The New England journal of medicine·2026
Same author

Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressiveness.

Communications medicine·2026
Same author

Contemporary Perioperative Outcomes of Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer.

Journal of endourology·2026
Same author

Germline polygenic score for prostate cancer aggressiveness.

medRxiv : the preprint server for health sciences·2026
Same author

Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.

JAMA internal medicine·2026
Same journal

Personalizing N-of-1 Trial Results to Facilitate Decision-Making.

JAMA network open·2026
Same journal

Prostate Cancer Screening-Where We've Been, Where We Are, and What Comes Next.

JAMA network open·2026
Same journal

Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults.

JAMA network open·2026
Same journal

At-Home Transvaginal Pelvic Ultrasonography and Image Quality in Premenopausal Women: A Nonrandomized Clinical Trial.

JAMA network open·2026
Same journal

Aerobic Exercise and Subthreshold Depressive Symptoms in Adolescents: Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2026
Same journal

Prefrontal Transcranial Pulse Stimulation for Major Depressive Disorder: A Randomized Clinical Trial.

JAMA network open·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.6K

Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.

Sagar A Patel1,2, Dattatraya Patil2, Joseph Smith3

  • 1Department of Radiation Oncology, Emory University, Atlanta, Georgia.

JAMA Network Open
|October 24, 2024
PubMed
Summary
This summary is machine-generated.

Radiotherapy after prostatectomy impacts quality of life. Early or late radiotherapy timing showed similar long-term outcomes for sexual, urinary, and bowel health in prostate cancer patients.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Related Experiment Videos

Last Updated: Jun 9, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Area of Science:

  • Oncology
  • Urology
  • Radiotherapy

Background:

  • The impact of radiotherapy (RT) timing after radical prostatectomy on long-term health-related quality of life (HRQOL) in prostate cancer patients is not well understood.
  • Patient-reported outcomes are crucial for evaluating treatment effectiveness beyond survival rates.

Purpose of the Study:

  • To assess long-term HRQOL up to 15 years post-prostatectomy in men who received RT or not.
  • To compare HRQOL outcomes between early (<12 months) and late (≥12 months) postprostatectomy RT.

Main Methods:

  • A prospective, multicenter, longitudinal cohort study involving 1203 men treated with radical prostatectomy.
  • HRQOL was measured using the Expanded Prostate Cancer Index Composite, assessing sexual, urinary, bowel, and hormonal domains.
  • Men were stratified into prostatectomy only, early RT, and late RT groups; outcomes were analyzed using mixed-effects models.

Main Results:

  • Postprostatectomy RT was associated with significant decreases in sexual, incontinence, and urinary irritation HRQOL compared to prostatectomy alone.
  • No significant difference in long-term HRQOL was observed between early and late RT groups.
  • Men receiving early RT showed improved recovery of sexual, continence, and urinary irritation scores compared to the late RT group.

Conclusions:

  • Postprostatectomy RT negatively impacts long-term HRQOL across multiple domains.
  • The timing of RT (early vs. late) does not appear to significantly affect long-term HRQOL outcomes.
  • Early RT may offer some advantages in the recovery of specific HRQOL domains compared to delayed RT.